TD Asset Management »

Oruka Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Oruka Therapeutics shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.2M 95k 22.83

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Oruka Therapeutics

Fairmount Funds Management
VR Adviser
Commodore Capital
Perceptive Advisors
Avidity Partners Management
Franklin Resources
Paradigm Biocapital Advisors
Braidwell
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Frazier Life Sciences Management
Redmile Group
Woodline Partners
Affinity Asset Advisors
Driehaus Capital Management

View all funds holding Oruka Therapeutics